Trinity Biotech plc TRIB

$ 0.8 4.9%

Annual report 2023
added 12-21-2024

Trinity Biotech plc Balance Sheet 2011-2024 | TRIB

Annual Balance Sheet Trinity Biotech plc

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	55.4 M	84.5 M	51.6 M	37.2 M	19.4 M	-7.29 M	-7.22 M	-9.03 M	-11.5 M	-3.1 M
Long Term Debt	-	-	-	82.7 M	99.8 M	81.9 M	94.8 M	96.5 M	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	106 M	107 M	90 M	106 M	116 M	130 M	23.8 M	22.5 M	15 M	6.9 M
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	83.4 M	94.3 M	119 M	133 M	126 M	108 M	127 M	141 M	-	-	-	28 M	20.2 M
Deferred Revenue	-	-	-	4.44 M	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	10.6 M	16.2 M	55.3 M	47.8 M	91.3 M	-	-	-	171 M	154 M
Total Assets	59.4 M	92.1 M	119 M	130 M	131 M	152 M	193 M	250 M	-	-	-	197 M	172 M
Cash and Cash Equivalents	3.69 M	6.58 M	25.9 M	27.3 M	15.2 M	30.3 M	57.6 M	77.1 M	102 M	-	-	-	-
Book Value	-23.9 M	-2.18 M	-319 K	-2.22 M	4.71 M	44.1 M	65.2 M	109 M	-	-	-	169 M	151 M
Total Shareholders Equity	-	-	-	-2.22 M	4.71 M	44.1 M	65.2 M	109 M	214 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Trinity Biotech plc

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	18.7 M	-	-	-	106 M	-	-	-	107 M	-	-	-	90 M	-	107 M	107 M	107 M	-	-	-	116 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	119 M	-	-	-	133 M	-	-	-	126 M	-	-	-	108 M	-	128 M	129 M	128 M	-	-	-	141 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	12.6 M	-	-	-	10.6 M	-	-	-	16.1 M	-	-	-	55.3 M	-	47.4 M	46.8 M	75.8 M	-	-	-	110 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	119 M	-	-	-	130 M	-	-	-	131 M	-	-	-	152 M	-	194 M	195 M	193 M	-	-	-	250 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	25.9 M	-	-	-	27.3 M	-	-	-	15.2 M	-	-	-	30.3 M	-	49.4 M	53.9 M	57.6 M	-	64 M	69.9 M	77.1 M	-	-	-	102 M	-	-	-	9.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	-319 K	-	-	-	-2.22 M	-	-	-	4.71 M	-	-	-	44.1 M	-	66.7 M	65.8 M	65.2 M	-	-	-	109 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	-319 K	-	-	-	-2.22 M	-	-	-	4.71 M	-	-	-	44.1 M	-	66.7 M	65.8 M	65.2 M	-	-	-	109 M	-	-	-	214 M	-	-	-	197 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency